Scarica l'app Stockscreener
13.24
8.37%
-1.21
Dopo l'orario di chiusura:
13.30
0.06
+0.45%
Replimune Group Inc Borsa (REPL) Ultime notizie
Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, - GlobeNewswire
REPL: TUDRIQEV launch targets rapid adoption in key accounts, with expansion and new indications ahead - TradingView
DEADLINE ALERT for REPL, DVLT, and UWMC: The Law Offices of - GlobeNewswire
Replimune faces class action over alleged nondi... - Pluang
Replimune at cantor healthcare conference: careful launch, broad pipeline By Investing.com - Investing.com Canada
REPL Investor Alert: Replimune Group, Inc. Securities Class Action NoticeContact SueWallSt - PR Newswire
Class action lawsuit filed against Replimune fo... - Pluang
Replimune faces securities lawsuit over alleged misleading FDA trial data claims, stock plunged 84%. - Pluang
REPL Deadline Alert: Levi & Korsinsky Reminds Replimune Group, Inc. (REPL) Investors of Securities Class Action Deadline on October 5, 2026 - PR Newswire
Replimune Group Stock Short Interest Falls to 43.08% - Quiver Quantitative
REPL Stock Lost 19% Of Its Value Today – Why Did The FDA Refuse Approval For Its Experimental Melanoma Drug? - Stocktwits
REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
REPL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Replimune Group, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
REPL Stock On Track To Hit All-Time Lows – Here’s Why This Analyst Slashed Price Target By 85% - Stocktwits
Price to earnings forward of Replimune Group, Inc. – NASDAQ:REPL - TradingView
2026-09-06 | REPL SHAREHOLDER ALERT - Stockhouse
Avoiding Lag: Real-Time Signals in (REPL) Movement - Stock Traders Daily
REPL Stock Soars on Plans of BLA Resubmission for Melanoma Combo Drug - Eastern Progress
Replimune shares plunge 84% after FDA rejects R... - Pluang
Deadline Alert: Replimune Group, Inc. (REPL) Shareholders - GlobeNewswire
Replimune investors urged to seek lead plaintiff role by Oct 5 deadline - scanx.trade
Class action lawsuit filed against Replimune af... - pluang.com
REPL DEADLINE: SueWallSt Reminds Replimune Group, Inc. Investors of Upcoming Securities Class Action Deadline - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming DeadlinesREPL - PR Newswire
Replimune to Present at the Cantor Global Healthcare Conference 2026 - The Manila Times
Robbins LLP Urges REPL Stockholders to Contact the Firm for Information About the Class Action Against Replimune Group, Inc. - Business Wire
REPL Shareholder Alert: Replimune Group, Inc. Securities Class Action LawsuitInvestors With Losses May Contact Levi & Korsinsky - Morningstar
Replimune Group stock hits 52-week high at 16.2 USD By Investing.com - Investing.com Canada
Replimune Group stock hits 52-week high at 16.2 USD - Investing.com
Bragar Eagel & Squire, P.C. Announces that a Class Action - GlobeNewswire
REPL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Replimune Group, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
REPL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Replimune Group, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - WBOC TV
Levi & Korsinsky Reminds Replimune Group, Inc. Investors of - GlobeNewswire
REPL Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Replimune Group, Inc. Securities LawsuitContact SueWallSt - PR Newswire
REPL Shareholder Alert: October 5, 2026 Lead Plaintiff Deadline in Replimune Group, Inc. Securities Class ActionContact Levi & Korsinsky - PR Newswire
Replimune Group, Inc. (REPL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Eastern Progress
Replimune Group stock hits 52-week high at 15.72 USD By Investing.com - Investing.com Nigeria
REPL Deadline Alert: Levi & Korsinsky Reminds Replimune - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc.REPL - Eastern Progress
Replimune Group Lawsuit Focuses on FDA Disclosure Issues and Sharp REPL Stock Drop - TipRanks
Robbins LLP Urges REPL Investors Who Lost Money Investing in Replimune to Contact the Firm for Information About Leading the Class Action - PR Newswire
DEADLINE ALERT for BZAI, BABA, ALAR, and REPL: The Law - GlobeNewswire
REPL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Replimune Group, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Why Did ABCL, REPL, ABNB Stocks Hit 52-Week Highs Today? - Stocktwits
Replimune (REPL) Results at a Glance: Profit Per Share Falls Below Its Benchmark; Market Response: Shares Move Lower 3.31% in the Available RecordFinancial Summary - vinanet.vn
REPL UPCOMING DEADLINE: SueWallSt Alerts Replimune Group, Inc. Stockholders of Securities Class ActionContact the Firm - PR Newswire
Replimune (REPL) Earnings Update: The Bottom-Line Figure Trails Its Comparison in the Latest Reading; Market Reaction: The Stock Ends Down 3.88% in the Latest ReadingDownward Estimate Revision - vinanet.vn
Replimune CFO Emily Hill sells $132,175 in stock for tax obligations - Investing.com Canada
Replimune Group (NASDAQ:REPL) CFO Sells $132,175.68 in Stock - MarketBeat
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Press Release: Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
REPL UPCOMING DEADLINE: Levi & Korsinsky Alerts Replimune Group, Inc. Stockholders of Securities Class ActionContact the Firm - PR Newswire
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):